Published:
Finkelstein Thompson LLP Announces Investigation of IMS Health Acquisition
WASHINGTON - (BUSINESS WIRE) - Finkelstein Thompson LLP is investigating potential claims on behalf of
shareholders of IMS Health ("IMS" or the "Company" ) (NYSE:RX) arising
from the Company's announcement of its intent to be acquired by
investment funds managed by TPG Capital ("TPG" ) and the CPP Investment
Board ("CPPIB" ).
Under the terms of the proposed agreement, IMS shareholders will receive
$22 cash for each share of IMS common stock they own. The transaction
has a total value of $5.2 billion, including the assumption of debt.
The investigation is focused on the potential unfairness of the price to
IMS shareholders and the process by which the IMS Board of Directors
considered and approved the transaction. As of September 30, 2009, the
Company had over $300 million in cash - a position that may not be
adequately valued in this proposed agreement.
If you are interested in discussing your rights as an IMS shareholder,
or have information relating to this investigation, please contact
Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by
email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering
outstanding representation to institutional and individual clients in
financial litigation, and has been appointed as lead or co-lead counsel
in dozens of shareholder class actions. Indeed, the firm has served in
leadership roles in cases that have recovered over $1 billion for
investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site
at www.finkelsteinthompson.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Finkelstein Thompson LLP
Donald Enright, 202-337-8000
Copyright © 2009, Business Wire, Inc., All rights reserved.
Copyright © 2009, NewsBlaze,
Daily NewsTags: Business wire, Legal, Law and Lawyers, district of columbia, Medical, Consulting, Accounting and other Professional Services
Search News
Daily News
